71 related articles for article (PubMed ID: 8108596)
21. [Changes in serum lipid levels and the spectrum of individual fatty acids in patients with chronic renal failure on conservative and hemodialysis treatment and their relation to dietary protein intake].
Orbetsova V; Simeonov P; Todorov K; Elazarova F
Vutr Boles; 1985; 24(4):63-70. PubMed ID: 4072171
[TBL] [Abstract][Full Text] [Related]
22. [Dyslipidemia in patients being treated with peritoneal dialysis].
Zharfbin A
Vnitr Lek; 2006 Nov; 52(11):1051-7. PubMed ID: 17165524
[TBL] [Abstract][Full Text] [Related]
23. The influence of several factors that intervene in hemodialysis on serum levels of triglycerides and free fatty acids.
Pérez-García A; Bretó M; Alvarińo J; Alegre B; Cruz JM
Clin Nephrol; 1979 Jul; 12(1):14-7. PubMed ID: 477051
[TBL] [Abstract][Full Text] [Related]
24. [The effect of heparin on the lipid level during hemodialysis].
Nikolaeva NP; Siniukhin VN; Khokhlov AP; Iarmolinskiĭ IS; Stetsiuk EA
Urol Nefrol (Mosk); 1990; (5):31-3. PubMed ID: 2264204
[TBL] [Abstract][Full Text] [Related]
25. Serum lipoprotein (a) levels in maintenance hemodialysis patients.
Okura Y; Saku K; Hirata K; Zhang B; Liu R; Ogahara S; Naito S; Kajiyama G; Arakawa K
Nephron; 1993; 65(1):46-50. PubMed ID: 8413789
[TBL] [Abstract][Full Text] [Related]
26. [Lipid behavior during hemodialysis using heparin and prostacyclin].
Camici M; Evangelisti L
Minerva Med; 1992 Dec; 83(12):801-4. PubMed ID: 1491759
[TBL] [Abstract][Full Text] [Related]
27. [Acute effects of sulodexide on the lipid profile and on antithrombin III in patients with chronic renal insufficiency in hemodialysis treatment].
Averna MR; Citarella P; Picone F; Capodicasa G; Galione A; Rini G; Notarbartolo A
Clin Ter; 1984 Jan; 108(2):111-4. PubMed ID: 6232045
[No Abstract] [Full Text] [Related]
28. The role of heparin in the changes of lipid patterns during a single hemodialysis.
Teraoka J; Matsui N; Nakagawa S; Takeuchi J
Clin Nephrol; 1982 Feb; 17(2):96-9. PubMed ID: 6802545
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of the effectiveness of hemodialysis using only heparin or prostacyclin with heparin].
Kuźniewski M; Sułowicz W
Przegl Lek; 1990; 47(3):328-31. PubMed ID: 2236625
[TBL] [Abstract][Full Text] [Related]
30. Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.
Raja R; Kramer M; Rosenbaum JL; Bolisay C; Krug M
Proc Clin Dial Transplant Forum; 1980; 10():39-42. PubMed ID: 7346852
[TBL] [Abstract][Full Text] [Related]
31. [Low molecular weight heparin: how does it modify lipid metabolism in chronic hemodialysis patients?].
Schneider H; Schmitt Y
Klin Wochenschr; 1991 Oct; 69(16):749-56. PubMed ID: 1662323
[TBL] [Abstract][Full Text] [Related]
32. Niceritrol reduces plasma lipoprotein(a) levels in patients undergoing maintenance hemodialysis.
Nakahama H; Nakanishi T; Uyama O; Sugita M; Miyazaki M; Yokokawa T; Okamura K; Tanaka Y; Shirai D
Ren Fail; 1993; 15(2):189-93. PubMed ID: 8469786
[TBL] [Abstract][Full Text] [Related]
33. [Lipaemic profile of patients subjected to long-term haemodialysis and acute changes associated with haemodialysis and the use of heparin (author's transl)].
Koslík S; Takác M
Sb Lek; 1981 Jul; 83(6-7):162-8. PubMed ID: 7268304
[No Abstract] [Full Text] [Related]
34. Pharmacokinetic aspects of digoxin in patients with terminal renal failure III. Effect of heparin.
van der Vijgh WJ; Oe PL
Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):560-2. PubMed ID: 598950
[TBL] [Abstract][Full Text] [Related]
35. [Effects of baoshen pill in treating chronic renal failure with long-term hemodialysis].
Ji SM; Li LS; Ji DX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Feb; 13(2):71-3, 67. PubMed ID: 8334339
[TBL] [Abstract][Full Text] [Related]
36. Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis.
Parra HJ; Mezdour H; Cachera C; Dracon M; Tacquet A; Fruchart JC
Clin Chem; 1987 May; 33(5):721. PubMed ID: 2952378
[No Abstract] [Full Text] [Related]
37. [Experiences with minimal intermittent heparinization in chronic dialysis patients].
Kovác A; Hünicke G; Bierwisch H
Z Urol Nephrol; 1980 May; 73(5):353-9. PubMed ID: 7456802
[TBL] [Abstract][Full Text] [Related]
38. Coagulation activation in extracorporeal hemodialysis.
Camici M; Evangelisti L; Balestri P; Cioni L; Rindi P; Sagripanti A; Meriggioli M; Giordani R
Int J Artif Organs; 1997 Mar; 20(3):163-5. PubMed ID: 9151152
[TBL] [Abstract][Full Text] [Related]
39. [Long-tern effect of hemodialysis without heparin on abnormal lipid metabolism in patients on regular dialysis treatment (author's transl)].
Matsui N; Shinoda T; Akiba T; Yoshiyama N; Nakagawa S; Takeuchi J; Teraoka J
Nihon Jinzo Gakkai Shi; 1981 Sep; 23(9):1225-32. PubMed ID: 7328898
[No Abstract] [Full Text] [Related]
40. [Activity of lipoprotein lipase and the effect of heparin on the blood lipids pattern in exogenous obesity].
Miturzyńska-Stryjecka H
Pol Tyg Lek; 1967 Jan; 22(5):161-4. PubMed ID: 6038965
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
